Royalty Report: Medical, Device, Diagnostic – Collection: 4832

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Medical
  • Device
  • Diagnostic
  • Surgical
  • Imaging
  • Equipment
  • Needles
  • Test/Monitoring
  • Ultrasound
  • Cancer
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 4832

License Grant
The Company transfers its rights to the Handheld Technology and to grant to Licensee a license to use ATL Technology in connection with the development, manufacture, sale, and maintenance of Handheld Ultrasound Devices; ultrasound system including a scanhead, a display device (or a video signal transmitter in lieu of a display device), and all intermediate components, together with all housings, controls, power sources, and output interfaces connected thereto, which do not weigh in the aggregate more than ten pounds.
License Property
Handheld Ultrasound Devices shall mean a self contained highly portable hand carried ultrasonic imaging device having a weight of ten pounds or less.  Typically, physicians utilize ultrasound imaging as an effective tool for noninvasive visual examination of soft tissue. Ultrasound systems use low-power, high-frequency sound waves emitted by a transducer to produce soft-tissue images.

Ultrasound systems use low-power, high-frequency sound waves emitted by a transducer to produce soft-tissue images. U.S. Pat. 5,722,412 Ultrasonic Array Transducer Transceiver for a Hand Held Ultrasonic Diagnostic Instrument and U.S. Appl. SN 08/863,936 Hand Held Ultrasonic Diagnostic Instrument with Digital Beamformer.  Ultrasonic Array Transducer Transceiver for a Hand Held Ultrasonic Diagnostic Instrument  by Blake Little, JJ Hwang, and Lauren Pflugrath, U.S. Appl. SN 08/826,543, filed April 3, 1997.

Field of Use
Typically, physicians utilize ultrasound imaging as an effective tool for noninvasive visual examination of soft tissue.

IPSCIO Record ID: 291147

License Grant
Licensor grants to Licensee, and direct and indirect customers of Licensed Licensee Products, a non-exclusive, non-transferable, perpetual, worldwide license under the Licensed Licensor Patents, without the right to sublicense, to make, have made, use, offer to sell, sell, import, or otherwise dispose of Licensed Licensee Products in the Territory.
License Property
Licensed Licensor Patents means U.S. Patent Nos. 5,722,412, 5,817,024, 6,364,839, 6,471,651, 6,569,101 and 6,962,566, and their corresponding Patent Families. For the avoidance of doubt, all of the patents and applications claiming priority to U.S. App. No. 08/672,782 (filed on June 28, 1996) are included in this definition.
5,722,412 – Hand held ultrasonic diagnostic instrument
5,817,024 – Hand held ultrasonic diagnostic instrument with digital beamformer
6,364,839 – Ultrasound diagnostic instrument having software in detachable scanhead

Licensed Licensor Products means current and future Licensor ultrasound products and any associated components, accessories and/or services that, absent the license granted to Licensor hereunder, would infringe one or more of the Licensed Licensee Patents.

Licensed Licensee Products means current and future Licensee ultrasound products and any associated components, accessories and/or services that, absent the license granted to Licensee hereunder, would infringe one or more of the Licensed Licensor Patents.

Licensed Licensee Patents means U.S. Patent Nos. 4,932,415, 5,584,294, 6,102,859, 6,120,447, 6,210,327 and 6,418,225, and their corresponding Patent Families.

Field of Use
This agreement pertains to the hand-carried ultrasound at the primary point-of-care, systems expedite diagnosis and treatment in acute and critical care settings and provide visual guidance for interventional procedures.
Ultrasound uses low power, high frequency sound waves to provide noninvasive, real-time images of the body’s soft tissue, organs and blood flow. Ultrasound can be cost effective by eliminating the need for more time intensive, invasive and expensive procedures and allowing for earlier diagnosis of diseases and conditions. Further, it does not expose the patient to ionizing radiation that is present in X-ray and computed tomography technology. To generate an ultrasound image, a clinician places the transducer on the skin or in a body cavity near or by the targeted area of interest. Tissues and bodily fluids reflect the sound waves emitted by the transducer, which then receives these reflections. Based on these reflections, the ultrasound system’s beamformer measures and organizes the sound waves and produces an image for visual examination, using digital or analog signal processing, or a combination of the two. Broadband digital signal processing technology, such as that used by our products, allows an ultrasound system to obtain and process greater amounts of information. Accordingly, digital ultrasound systems produce higher resolution images than analog and hybrid analog/digital ultrasound machines.

IPSCIO Record ID: 28166

License Grant
Licensor grants an exclusive worldwide license to the Licensed Technology to manufacture, make, have made, promote, market, use, distribute, sell and have sold Products incorporating or utilizing, and to otherwise commercialize and exploit the Licensed Technology.
License Property
Licensor is the owner of technology and patents relating to enhancing the visualization of biopsy needles or other metallic devices being guided by ultrasound.

The Licensed Technology means the ColorMark(R) technology, and shall include all Licensor's U.S. and foreign patents and patent applications, currently existing or existing in the future, related thereto.

Field of Use
Licensee is involved in the development and distribution of medical equipment.

IPSCIO Record ID: 203978

License Grant
The Canadian Licensor grants to Licensee an exclusive, worldwide license, with the right to grant and authorize sublicenses, to Licensors entire interest in and to the Licensed Patents within the Field to make, have made, use, import, have imported, sell, offer for sale and otherwise exploit and distribute Licensed Products within the Field, and practice any method, process or procedure included within the Licensed Patents in the Field.
License Property
The licensed patents are for Two-Dimensional and Three-Dimensional Digital Ultrasound Tracking Systems for surgery.  The Licensed Product means a product within the scope of one or more Valid Claims of the Licensed Patents in the country of manufacture or sale;  produced, processed or otherwise manufactured by a process or method within the scope of one or more Valid Claims of the Licensed Patents in the country of such manufacture; or; used in a process and/or method within the scope of one or more Valid Claims of the Licensed Patents in the country where such product is made or sold.
Field of Use
The Field shall mean use of any medical device and procedure applications in and on the heart that utilize essentially real-time triangulation algorithms to determine the three-dimensional position of transducers, excluding procedures solely and directly related to heart valve surgery.

IPSCIO Record ID: 130224

License Grant
Sublicensor, with the consent of its licensor, grants to Sublicensee an exclusive, worldwide license, including the right to grant sublicenses, without limitation, to manufacture, use, sell, import and offer for sale Products under all Sublicensors right, title and interest in the Patent Rights and Technology.
License Property
Sublicensor is the exclusive licensee of the patents and applications, specifically US patents 5,713,356, 6,102,857, 6,490,470, 6,633,774 and pending patents US No. 20040127783, European Union No. 97944607.7,  Japan No. 516884/98, and Canada No. 2187701.  The patents relate to imaging properties of tissue based upon differential absorption of electromagnetic waves in differing tissue types by photo-acoustic techniques.
Field of Use
This sublicense is used for breast tissue imaging.

IPSCIO Record ID: 4807

License Grant
The Company hereby grants within the Field of Use the exclusive rights to several ultrasound technologies for use in the field of electrophysiology.
License Property
Echomark (5,076,278)  means EchoCath's proprietary catheter positioning system which is covered by the Patents.

EchoEye (5,373,845) means proprietary technology for allowing clinicians to view tissues and organs in three-dimensional real-time and provide forward looking intravascular images and guidance for ultrasound guided procedures, and covered by the Patents.

ColorMark (5,329,927) means proprietary needle and stylete positioning system which is covered by the Patents.

Field of Use
Field of Use shall include the application of the EchoMark, EchoEye and ColorMark technologies as they apply to any and all systems and products which are designed and/or manufactured for electrophysiology applications to include but not limited to mapping, ablation and internal cardioversion.  The Field of Use specifically excludes permanent pacemaker leads and permanent defibrillator leads attached to permanent implantable pulse generators.

IPSCIO Record ID: 28044

License Grant
The Licensor has an Agreement with the Licensee, which represents the development of an ultrasonic sergical device, and as a result of that joint development; patents are co-owned by both parties.
License Property
The Licensor designs, manufactures, develops and markets minimally invasive ultrasonic surgical device products.

Technology relates to laparoscopic products, which uses high frequency sound waves to coagulate and divide tissue for both open and laparoscopic surgery.

Field of Use
The AutoSonix ultrasound cutting and coagulating system is distributed and marketed for the Licensor through an agreement with the Licensee.

IPSCIO Record ID: 26489

License Grant
The Company hereby grants to Licensee an exclusive, worldwide, royalty-bearing, limited license under the Licensed Technology to make, have made, import, use, sell and have sold the Devices solely within the Field of Use.
License Property
U.S. 5,860,934                    Method and Device for Mechanical Imaging of Breast         Issued 01/19/99

(CIP of App. 07/994,109)

U.S. 5,833,633                    Device for Breast Haptic Examination                       Filed 11/03/97

(CIP of 5,524,636)                                                                           Issued 11/10/98

U.S. 5,785,633                    Method and Device for Mechanical Imaging of Prostate       Filed 02/27/96

(CIP of 5,524,636)                                                                           Issued 07/28/98

U.S. 5,836,894                    Apparatus for Measuring Mechanical Parameters of the       Filed 06/10/97

(CIP of 5,524,636)                Prostate and for Imaging the Prostate Using such           Issued 11/17/98

U.S. 5,922,018                    Method for Using a Transrectal Probe to Mechanically        Filed 06/10/97

(CIP of 5,524,636)                Image the Prostate Gland                                    Issued 07/13/99

U.S. 5,524,636                    Method and Apparatus for Elasticity Imaging                Filed 12/21/92

U.S. 5,265,612                    Intracavity Ultrasonic Device for Elasticity Imaging       Filed 12/21/92

U.S. 6,142,959                    Device for Palpation and Mechanical Imaging of the         Filed 07/22/99

                                  Prostate                                                   Issued 11/07/00

PCT/US00/19756                    Device for Palpation and Mechanical Imaging of the         Filed 07/21/00

                                  Prostate

U.S. 09/843,056                   Apparatus and Method for Mechanical Imaging of Breast      Filed 04/26/01

PCT/US01/13551                    Apparatus and Method for Mechanical Imaging of Breast      Filed 4/26/01

U.S. 60/200,433                   Apparatus and Method for Mechanical Imaging of Breast      Filed 4/28/00

U.S. 09/819,419                   Real Time Mechanical Imaging of the Prostate               Filed 03/28/01

Field of Use
Field of Use shall mean the diagnosis of and the treatment of (a) benign prostatic hyperplasia; (b) prostatitis; © prostate cancer; or (d) any other conditions of or disorders of the prostate, whether healthy or diseased, and any other condition of urologic disorder which may be diagnosed, imaged or treated using any diagnostic or imaging process.  Prostate imaging system and related patented technology.

IPSCIO Record ID: 4346

License Grant
An Irish leading global provider of healthcare products, today announced that it has won a court decision ruling of patent infringement against a company with a Harmonic line of ultrasonic surgical products.
License Property
The federal court found that US Patents 6,063,050, 6,468,286, and 6,682,544, each relating to ultrasonic cutting and coagulation surgical devices were infringed.
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 2309

License Grant
The second agreement gives Company exclusive rights from the government organization to manufacture and distribute NASA’s high voltage isolation transformer (patent no. 4,510,476) and high voltage power supply (patent no. 4,517,472).  This technology allows the Company products (incl. FluoroScan System) to produce low levels of radiation.
License Property
The FluoroScan System is a low intensity, real time X-ray imaging device which provides high resolution images at radiation levels and at a cost well below those of conventional X-ray and fluoroscopic equipment.   The FluoroScan System technology is based on a micro channel plate image intensifier commonly known as a night vision intensifier.

This invention relates to electrical power supplies and, more particularly, to a power supply for providing a plurality of high voltage output signals.  High voltage power supplies have typically been low frequency networks characterized principally by their mass, bulk and relative inefficiency.  Recent advances in such fields as diagnostic x-ray devices (e.g., the Low Intensity X-ray and Gamma-ray Imaging Device disclosed in U.S. Pat. No. 4,142,101) have established a demand for portable, battery driven power supplies able to deliver a plurality of regulated, static output voltages on the order of tens of kilowatts for periods of several hours. The operational characteristics of such devices usually require that each potential furnished by a power supply be separately adjustable.

Field of Use
The rights granted apply in such fields as diagnostic x-ray devices.

IPSCIO Record ID: 5729

License Grant
LICENSEE hereby grants back to LICENSOR the co-exclusive rights under the license granted to LICENSEE.

LICENSEE is granted an exclusive worldwide license to certain patent rights and know how relating to the determination of glucose concentration in body fluid which glucose is obtained using ultrasonic techniques.

LICENSOR will have worldwide coexclusive rights to develop and market LICENSOR's continuous transdermal glucose monitoring system using the SonoPrep ultrasonic skin permeation technology for the hospital intensive care unit (ICU) market.

License Property
Licensor Patent Rights

1

US 6,234,990 B2

US 6,234,990 B1

WO 9800194 A2

EP 0925088 A2

2

WO 0170330 A2

EP 1225831 A2

3

U.S. 6,190,315 B1

WO 99348578 A1

EP 1045714 A1

4

WO 0035357 A1

EP 1139886 A1

5

WO 0035351 A

Field of Use
Field of Use shall mean the area of determination of glucose concentration in body fluid which glucose is obtained using ultrasonic techniques.

IPSCIO Record ID: 5787

License Grant
Doctor hereby grants an exclusive license to make, have made, use, sell and have sold the licensed products in the United States and worldwide under the Patent (5,380,411) Rights in the licensed field.  Intellectual property relates to methods of destroying cells by applying ultrasound, wherein the cells are in a preparation containing or producing microbubbles.  Nanobubbles and ultrasound for a wide range of therapies, including the elimination of blood clots in various parts of the body.
License Property
5,380,411 – Ultrasound or shock wave work process and preparation for carrying out same
Field of Use
Licensed Field shall mean all fields.

IPSCIO Record ID: 25894

License Grant
Licensor hereby grants to Licensee an exclusive worldwide right and license under the Patent Rights and Know-How in the Field of Use, with the right to grant sublicenses, to make, have made, use, import, and sell any Licensed Products and/or Processes during the term hereof.   Licensors intellectual property relates to continuous transdermal glucose monitoring system utilizing ultrasonic techniques.
License Property
It has completed the first prototypes of its continuous glucose monitor using proprietary ultrasonic skin permeation technology for the hospital intensive care unit (ICU), and expects to begin human clinical studies in early 2006.

Licensor Patent Rights

1

US 6,234,990 B2

US 6,234,990 B1

WO 9800194 A2

EP 0925088 A2

2

WO 0170330 A2

EP 1225831 A2

3

U.S. 6,190,315 B1

WO 99348578 A1

EP 1045714 A1

4

WO 0035357 A1

EP 1139886 A1

5

WO 0035351 A

Field of Use
Field of Use shall mean the area of determination of glucose concentration in body fluid which glucose is obtained using ultrasonic techniques.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.